Escalon Medical Corp. (OTCMKTS:ESMC) Short Interest Update

Escalon Medical Corp. (OTCMKTS:ESMC) was the recipient of a large increase in short interest during the month of May. As of May 15th, there was short interest totaling 171,227 shares, an increase of 1,141,413.3% from the April 30th total of 15 shares. Based on an average daily trading volume, of 83,991 shares, the short-interest ratio is currently 2.0 days. Approximately 2.4% of the company’s shares are short sold.

Escalon Medical Trading Down 9.5%

Shares of OTCMKTS ESMC traded down $0.02 during midday trading on Wednesday, hitting $0.19. The stock had a trading volume of 1,173 shares, compared to its average volume of 25,302. The company has a market capitalization of $1.41 million, a price-to-earnings ratio of 1.73 and a beta of 0.11. Escalon Medical has a 1-year low of $0.10 and a 1-year high of $0.46. The company has a quick ratio of 1.94, a current ratio of 2.59 and a debt-to-equity ratio of 0.04. The company has a fifty day moving average price of $0.19 and a 200 day moving average price of $0.18.

Escalon Medical (OTCMKTS:ESMC) last released its quarterly earnings data on Friday, May 15th. The medical equipment provider reported $0.16 earnings per share for the quarter. The business had revenue of $2.61 million for the quarter. Escalon Medical had a negative return on equity of 21.42% and a net margin of 16.17%.

Escalon Medical Company Profile

Escalon Medical Corp. engages in the development, manufacturing, marketing, and distribution of medical devices and pharmaceuticals in the area of ophthalmology in the United States and internationally. It offers A-Scan, which provides information about the internal structure of the eye; B-Scan, a diagnostic tool that supplies information to physicians where the media within the eye are cloudy or opaque; UBM, a high frequency/high resolution ultrasound device, which provides detailed information about the anterior segment of the eye; and Pachymeter that measures the thickness of cornea.